Abbott Defeated In HCV Patent Feud
Proving that its optimism was well-founded, Belgian biotechnology company Innogenetics N.V. has been handed a victory in its long-running battle with Abbott Laboratories over a hepatitis C virus genotyping patent....To view the full article, register now.
Already a subscriber? Click here to view full article